1. Home
  2. EXAS vs CIEN Comparison

EXAS vs CIEN Comparison

Compare EXAS & CIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • CIEN
  • Stock Information
  • Founded
  • EXAS 1995
  • CIEN 1992
  • Country
  • EXAS United States
  • CIEN United States
  • Employees
  • EXAS N/A
  • CIEN N/A
  • Industry
  • EXAS Medical Specialities
  • CIEN Telecommunications Equipment
  • Sector
  • EXAS Health Care
  • CIEN Utilities
  • Exchange
  • EXAS Nasdaq
  • CIEN Nasdaq
  • Market Cap
  • EXAS 8.8B
  • CIEN 9.3B
  • IPO Year
  • EXAS N/A
  • CIEN 1997
  • Fundamental
  • Price
  • EXAS $43.06
  • CIEN $59.60
  • Analyst Decision
  • EXAS Strong Buy
  • CIEN Buy
  • Analyst Count
  • EXAS 18
  • CIEN 13
  • Target Price
  • EXAS $70.59
  • CIEN $81.92
  • AVG Volume (30 Days)
  • EXAS 2.0M
  • CIEN 2.9M
  • Earning Date
  • EXAS 05-07-2025
  • CIEN 03-11-2025
  • Dividend Yield
  • EXAS N/A
  • CIEN N/A
  • EPS Growth
  • EXAS N/A
  • CIEN N/A
  • EPS
  • EXAS N/A
  • CIEN 0.55
  • Revenue
  • EXAS $2,758,867,000.00
  • CIEN $4,049,506,000.00
  • Revenue This Year
  • EXAS $13.02
  • CIEN $12.01
  • Revenue Next Year
  • EXAS $13.02
  • CIEN $9.09
  • P/E Ratio
  • EXAS N/A
  • CIEN $112.33
  • Revenue Growth
  • EXAS 10.37
  • CIEN N/A
  • 52 Week Low
  • EXAS $40.62
  • CIEN $43.30
  • 52 Week High
  • EXAS $79.62
  • CIEN $101.44
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 36.15
  • CIEN 30.65
  • Support Level
  • EXAS $44.00
  • CIEN $63.74
  • Resistance Level
  • EXAS $47.23
  • CIEN $70.57
  • Average True Range (ATR)
  • EXAS 1.57
  • CIEN 2.59
  • MACD
  • EXAS 0.06
  • CIEN -0.01
  • Stochastic Oscillator
  • EXAS 15.86
  • CIEN 4.25

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.

About CIEN Ciena Corporation

Ciena Corp is a network and technology company. It provides network hardware, software, and services that support the transport, switching, aggregation, service delivery, and management of video, data, and voice traffic on communications networks. It serves various industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises world-wide. The business activities function through Networking Platforms which generates maximum revenue; Platform Software and Services; Blue Planet Automation Software, and Global Services segments. Geographically, the company derives a majority of its revenue from the Americas, and the rest from the Asia-Pacific (APAC), and Europe, Middle East, and Africa (EMEA) region.

Share on Social Networks: